Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 12, 2021
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
Wed, August 11, 2021
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
A.J. Rice Maintained (AMED) at Buy with Decreased Target to $250 on, Aug 11th, 2021
A.J. Rice of Credit Suisse, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $330 to $250 on, Aug 11th, 2021.
A.J. has made no other calls on AMED in the last 4 months.
There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 2 agree with A.J.'s Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $237 on, Friday, August 6th, 2021
- Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021
These are the ratings of the 3 analyists that currently disagree with A.J.
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021
- John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $265 on, Friday, August 6th, 2021
